Last 7 days
-1.8%
Last 30 days
-3.8%
Last 90 days
-7.6%
Trailing 12 Months
-2.9%
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 1.2B | 1.2B | 1.2B | 0 |
2022 | 993.2M | 1.0B | 1.1B | 1.1B |
2021 | 870.5M | 903.4M | 933.8M | 953.2M |
2020 | 988.5M | 945.6M | 902.5M | 883.9M |
2019 | 967.6M | 976.7M | 987.7M | 999.3M |
2018 | 903.9M | 922.3M | 938.5M | 951.8M |
2017 | 886.1M | 887.1M | 892.2M | 898.4M |
2016 | 908.8M | 905.4M | 905.9M | 900.4M |
2015 | 910.4M | 899.3M | 891.4M | 893.0M |
2014 | 938.5M | 943.5M | 935.3M | 925.0M |
2013 | 892.0M | 935.1M | 952.6M | 947.4M |
2012 | 727.8M | 733.8M | 772.5M | 828.7M |
2011 | 676.7M | 684.2M | 696.8M | 711.2M |
2010 | 645.4M | 654.4M | 664.1M | 675.8M |
2009 | 597.9M | 609.8M | 621.7M | 633.5M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Nov 01, 2023 | galvin roy | sold (taxes) | -13,822 | 86.39 | -160 | president, global plasma & bc |
Oct 20, 2023 | strong stewart w | sold (taxes) | -10,686 | 89.05 | -120 | president, global hospital |
Oct 20, 2023 | basil michelle l | sold (taxes) | -17,542 | 89.05 | -197 | evp and general counsel |
Sep 15, 2023 | miller laurie a. | sold (taxes) | -18,833 | 90.11 | -209 | svp, human resources |
Sep 12, 2023 | strong stewart w | sold | -20,668 | 90.65 | -228 | president, global hospital |
Sep 11, 2023 | lingamneni anila | sold | -207,450 | 90.00 | -2,305 | evp, chief technology officer |
Sep 05, 2023 | dockendorff charles j | sold | -895,651 | 87.68 | -10,215 | - |
Aug 04, 2023 | bryant diane m | acquired | - | - | 2,226 | - |
Aug 04, 2023 | dockendorff charles j | acquired | - | - | 2,226 | - |
Aug 04, 2023 | kroll mark w | acquired | - | - | 2,226 | - |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Nov 24, 2023 | DEUTSCHE BANK AG\ | reduced | -1.5 | 638,449 | 18,173,500 | 0.01% |
Nov 22, 2023 | Graham Capital Management, L.P. | sold off | -100 | -482,062 | - | -% |
Nov 21, 2023 | Walleye Capital LLC | new | - | 202,182 | 202,182 | -% |
Nov 21, 2023 | COMERICA BANK | reduced | -21.72 | 1,909,310 | 1,910,310 | 0.01% |
Nov 17, 2023 | JACOBS LEVY EQUITY MANAGEMENT, INC | sold off | -100 | -15,108,900 | - | -% |
Nov 16, 2023 | Financial Gravity Asset Management, Inc. | sold off | -100 | -730 | 39.00 | -% |
Nov 16, 2023 | Orion Capital Management LLC | new | - | 23,828 | 23,828 | 0.01% |
Nov 15, 2023 | HARBOUR INVESTMENTS, INC. | unchanged | - | 222 | 4,479 | -% |
Nov 15, 2023 | PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | reduced | -0.6 | 11,000 | 253,000 | -% |
Nov 15, 2023 | Toroso Investments, LLC | added | 12.19 | 60,571 | 396,571 | 0.01% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 13, 2023 | capital research global investors | 11.8% | 5,956,064 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 10.36% | 5,242,836 | SC 13G/A | |
Feb 06, 2023 | wellington management group llp | 7.97% | 4,034,753 | SC 13G/A | |
Jan 26, 2023 | blackrock inc. | 11.7% | 5,898,620 | SC 13G/A | |
Jan 20, 2023 | blackrock inc. | 11.7% | 5,898,620 | SC 13G/A | |
Apr 08, 2022 | capital research global investors | 10.7% | 5,452,006 | SC 13G | |
Feb 14, 2022 | neuberger berman group llc | 7.59% | 3,876,521 | SC 13G/A | |
Feb 11, 2022 | capital research global investors | 4.0% | 2,049,133 | SC 13G/A | |
Feb 10, 2022 | vanguard group inc | 9.55% | 4,880,936 | SC 13G/A | |
Feb 10, 2022 | wellington management group llp | 10.83% | 5,537,538 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Nov 03, 2023 | 4 | Insider Trading | |
Nov 02, 2023 | 8-K | Current Report | |
Nov 02, 2023 | 10-Q | Quarterly Report | |
Oct 24, 2023 | 4 | Insider Trading | |
Oct 24, 2023 | 4 | Insider Trading | |
Oct 12, 2023 | 8-K/A | Current Report | |
Oct 10, 2023 | 8-K | Current Report | |
Sep 18, 2023 | 4 | Insider Trading | |
Sep 13, 2023 | 4 | Insider Trading | |
Sep 13, 2023 | 4 | Insider Trading |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABT | 179.2B | 40.0B | 10.05% | -2.88% | 34.72 | 4.48 | -11.26% | -34.57% |
BDX | 71.3B | 19.4B | -6.71% | 1.22% | 44.09 | 3.79 | 2.66% | -16.58% |
BAX | 18.2B | 15.0B | 11.91% | -35.29% | 7.03 | 1.21 | 3.01% | 209.09% |
ALGN | 16.8B | 3.8B | -13.48% | 11.82% | 46.33 | 4.42 | -1.48% | -28.97% |
MID-CAP | ||||||||
HSIC | 9.1B | 12.6B | 2.80% | -13.35% | 19.86 | 0.72 | -0.94% | -29.54% |
BIO | 9.1B | 2.7B | 7.69% | -22.67% | -57.06 | 3.34 | -3.01% | 97.36% |
ATR | 8.4B | 3.4B | 4.90% | 20.89% | 30 | 2.45 | 3.13% | 18.17% |
XRAY | 6.6B | 3.9B | -1.54% | 1.10% | -30.43 | 1.69 | -2.62% | 73.28% |
PDCO | 3.1B | 6.5B | 5.03% | 11.86% | 14.6 | 0.48 | 1.83% | 10.70% |
AXNX | 2.9B | 342.6M | 11.80% | -12.52% | -240.39 | 8.41 | 42.19% | 84.14% |
SMALL-CAP | ||||||||
AHCO | 1.2B | 3.1B | 19.36% | -60.32% | -2.73 | 0.37 | 7.95% | -550.16% |
ANIK | 310.6M | 163.3M | 13.17% | -30.31% | -12.64 | 1.9 | 7.14% | -56.09% |
ANGO | 280.7M | 335.9M | 7.28% | -49.08% | 43.55 | 0.84 | 4.71% | 116.39% |
APYX | 88.3M | 50.3M | 4.17% | 45.35% | -5.83 | 1.76 | 3.23% | 20.81% |
AEMD | 4.2M | 3.8M | 13.42% | -61.23% | -0.36 | 1.11 | 17.30% | 10.67% |
Income Statement (Quarterly) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Revenue | 2.2% | 318 | 311 | 304 | 305 | 297 | 261 | 265 | 260 | 240 | 229 | 225 | 240 | 209 | 196 | 238 | 259 | 253 | 238 | 249 | 247 | 242 |
Gross Profit | 1.9% | 171 | 167 | 156 | 159 | 158 | 142 | 136 | 139 | 123 | 108 | 82.00 | 120 | 106 | 90.00 | 114 | 128 | 127 | 116 | 111 | 111 | 112 |
Operating Expenses | 19.0% | 135 | 114 | 121 | 115 | 111 | 111 | 117 | 103 | 98.00 | 107 | 103 | 80.00 | 47.00 | 78.00 | 88.00 | 87.00 | 77.00 | 129 | 87.00 | 83.00 | 86.00 |
S&GA Expenses | 12.2% | 105 | 93.00 | 97.00 | 95.00 | 92.00 | 92.00 | 92.00 | 81.00 | 76.00 | 91.00 | 84.00 | 66.00 | 64.00 | 62.00 | 53.00 | 78.00 | 78.00 | 73.00 | 54.00 | 74.00 | 77.00 |
R&D Expenses | 0.1% | 13.00 | 13.00 | 16.00 | 13.00 | 11.00 | 11.00 | 13.00 | 10.00 | 11.00 | 13.00 | 11.00 | 8.00 | 7.00 | 8.00 | 9.00 | 7.00 | 7.00 | 7.00 | 9.00 | 9.00 | 9.00 |
EBITDA Margin | - | - | - | 0.21* | - | 0.19* | 0.18* | 0.17* | 0.13* | 0.13* | 0.17* | 0.19* | 0.25* | 0.26* | 0.24* | 0.21* | 0.21* | 0.20* | - | - | - | - |
Interest Expenses | - | - | - | - | - | - | - | - | - | - | 1.00 | 2.00 | 1.00 | 2.00 | 3.00 | 2.00 | 4.00 | 3.00 | 4.00 | 4.00 | 4.00 | 3.00 |
Income Taxes | -24.5% | 8.00 | 11.00 | 3.00 | 9.00 | 8.00 | 6.00 | 6.00 | 8.00 | 5.00 | 1.00 | -16.38 | 5.00 | 7.00 | -2.55 | 4.00 | 8.00 | 8.00 | -9.25 | 1.00 | 7.00 | 4.00 |
Earnings Before Taxes | -36.4% | 33.00 | 52.00 | 33.00 | 42.00 | 41.00 | 25.00 | 15.00 | 31.00 | 20.00 | -3.01 | -27.40 | 37.00 | 55.00 | 8.00 | 22.00 | 38.00 | 45.00 | -17.73 | 22.00 | 25.00 | 23.00 |
EBT Margin | - | - | - | 0.12* | 0.11* | 0.10* | 0.09* | 0.06* | 0.02* | 0.03* | 0.07* | 0.08* | 0.14* | 0.14* | 0.12* | 0.09* | 0.09* | - | - | - | - | - |
Net Income | -39.3% | 25.00 | 41.00 | 29.00 | 33.00 | 33.00 | 20.00 | 10.00 | 23.00 | 15.00 | -4.45 | -11.04 | 32.00 | 48.00 | 11.00 | 18.00 | 30.00 | 37.00 | -8.48 | 21.00 | -8.48 | 19.00 |
Net Income Margin | - | - | - | 0.10* | 0.08* | 0.08* | 0.07* | 0.04* | 0.02* | 0.03* | 0.07* | 0.09* | 0.12* | 0.12* | 0.10* | 0.08* | 0.08* | - | - | - | - | - |
Free Cashflow | - | - | - | 68.00 | 48.00 | 51.00 | -3.47 | 33.00 | 36.00 | 23.00 | -15.60 | -10.09 | 57.00 | 21.00 | 4.00 | 36.00 | 59.00 | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Assets | 2.5% | 2,011 | 1,962 | 1,935 | 1,878 | 1,865 | 1,821 | 1,860 | 1,831 | 1,801 | 1,794 | 1,820 | 1,318 | 1,418 | 1,433 | 1,267 | 1,238 | 1,191 | 1,260 | 1,275 | 1,228 | 1,266 |
Current Assets | 8.0% | 866 | 802 | 770 | 706 | 716 | 688 | 756 | 729 | 699 | 684 | 694 | 668 | 760 | 759 | 604 | 583 | 568 | 615 | 576 | 516 | 553 |
Cash Equivalents | 22.8% | 351 | 286 | 284 | 224 | 241 | 215 | 259 | 237 | 192 | 173 | 192 | 189 | 279 | 276 | 137 | 126 | 112 | 190 | 169 | 155 | 200 |
Inventory | -1.2% | 286 | 289 | 259 | 256 | 255 | 278 | 293 | 306 | 323 | 327 | 323 | 300 | 305 | 295 | 270 | 254 | 245 | 222 | 194 | 169 | 164 |
Net PPE | 1.1% | 308 | 304 | 311 | 313 | 308 | 288 | 258 | 239 | 224 | 215 | 218 | 240 | 240 | 243 | 253 | 268 | 264 | 277 | 344 | 351 | 345 |
Goodwill | -0.1% | 465 | 466 | 466 | 466 | 465 | 466 | 467 | 468 | 469 | 466 | 466 | 216 | 215 | 217 | 8.00 | 211 | 211 | 211 | 211 | 211 | 211 |
Current Liabilities | 11.5% | 264 | 237 | 252 | 227 | 262 | 180 | 442 | 355 | 288 | 228 | 253 | 194 | 339 | 408 | 275 | 257 | 240 | 294 | 236 | 211 | 189 |
LT Debt, Current | 0.0% | 14.00 | 14.00 | 12.00 | 10.00 | 58.00 | 7.00 | 214 | 144 | 83.00 | 17.00 | 17.00 | 17.00 | 167 | 231 | 77.00 | 62.00 | 57.00 | 118 | 28.00 | 17.00 | 13.00 |
LT Debt, Non Current | -0.4% | 749 | 751 | 754 | 757 | 760 | 763 | 559 | 633 | 698 | 767 | 691 | 293 | 297 | 297 | 306 | 310 | 314 | 318 | 322 | 327 | 331 |
Shareholder's Equity | 3.4% | 894 | 865 | 818 | 776 | 729 | 770 | 749 | 731 | 699 | 677 | 732 | 719 | 668 | 609 | 587 | 575 | 584 | 591 | 668 | 591 | 701 |
Retained Earnings | 8.8% | 309 | 284 | 253 | 224 | 204 | 222 | 202 | 193 | 169 | 155 | 158 | 169 | 137 | 89.00 | 79.00 | 70.00 | 86.00 | 99.00 | 161 | 141 | 194 |
Additional Paid-In Capital | 1.2% | 617 | 610 | 595 | 587 | 564 | 580 | 572 | 567 | 558 | 551 | 603 | 579 | 569 | 563 | 553 | 538 | 534 | 525 | 536 | 531 | 530 |
Shares Outstanding | 0.1% | 51.00 | 51.00 | 50.00 | 50.00 | 51.00 | 51.00 | 51.00 | 51.00 | 51.00 | 51.00 | 51.00 | 51.00 | 51.00 | 50.00 | 50.00 | 51.00 | 51.00 | 51.00 | 51.00 | 51.00 | 52.00 |
Cashflow (Quarterly) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Cashflow From Operations | 419.4% | 99,124,000 | 19,086,000 | 79,611,000 | 64,415,000 | 87,039,000 | 41,993,000 | 68,050,000 | 62,433,000 | 43,460,000 | -1,680,000 | 1,547,000 | 66,291,000 | 29,155,000 | 11,812,000 | 46,406,000 | 79,282,000 | 29,901,000 | 2,628,000 | 20,638,000 | 58,164,000 | 57,357,000 |
Share Based Compensation | -4.0% | 6,706,000 | 6,989,000 | 7,058,000 | 7,491,000 | 5,735,000 | 5,299,000 | 5,097,000 | 6,455,000 | 5,979,000 | 6,828,000 | 7,110,000 | 6,287,000 | 5,952,000 | 6,167,000 | 5,399,000 | 5,325,000 | 5,000,000 | 4,730,000 | 4,445,000 | 4,782,000 | 4,582,000 |
Cashflow From Investing | -64.7% | -25,135,000 | -15,261,000 | -18,006,000 | -36,500,000 | -31,068,000 | -58,214,000 | -34,512,000 | -15,462,000 | -20,520,000 | -15,851,000 | -429,100,000 | -9,581,000 | 37,135,000 | -23,896,000 | -45,135,000 | -19,866,000 | 5,964,000 | 1,861,000 | -13,217,000 | -27,585,000 | -48,082,000 |
Cashflow From Financing | -1099.3% | -7,172,000 | -598,000 | -1,603,000 | -49,680,000 | -25,686,000 | -23,395,000 | -8,765,000 | -2,035,000 | -3,315,000 | -1,634,000 | 432,759,000 | -149,940,000 | -64,318,000 | 148,951,000 | 11,372,000 | -46,153,000 | -112,517,000 | 16,090,000 | 6,995,000 | -76,207,000 | -79,000 |
Buy Backs | - | - | - | - | - | 75,000,000 | - | - | - | - | - | - | - | - | - | - | 50,000,000 | 50,000,000 | 75,000,000 | 2,500,000 | 75,000,000 | - |
CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2023 | Oct. 01, 2022 | Sep. 30, 2023 | Oct. 01, 2022 | |
Income Statement [Abstract] | ||||
Net revenues | $ 318,183 | $ 297,485 | $ 629,515 | $ 558,943 |
Cost of goods sold | 147,673 | 139,607 | 291,740 | 258,802 |
Gross profit | 170,510 | 157,878 | 337,775 | 300,141 |
Operating expenses: | ||||
Research and development | 12,665 | 10,896 | 25,313 | 21,798 |
Selling, general and administrative | 104,901 | 92,029 | 198,386 | 184,256 |
Amortization of acquired intangible assets | 7,222 | 8,221 | 14,695 | 16,588 |
Impairment of assets | 10,419 | 0 | 10,419 | 0 |
Total operating expenses | 135,207 | 111,146 | 248,813 | 222,642 |
Operating income | 35,303 | 46,732 | 88,962 | 77,499 |
Interest and other expense, net | (2,471) | (5,673) | (4,540) | (10,946) |
Income before provision for income taxes | 32,832 | 41,059 | 84,422 | 66,553 |
Provision for income taxes | 7,924 | 7,862 | 18,472 | 13,479 |
Net income | $ 24,908 | $ 33,197 | $ 65,950 | $ 53,074 |
Basic income (loss) per share (in dollars per share) | $ 0.49 | $ 0.65 | $ 1.30 | $ 1.04 |
Diluted income (loss) per share (in dollars per share) | $ 0.48 | $ 0.64 | $ 1.28 | $ 1.03 |
Weighted average shares outstanding | ||||
Basic (in shares) | 50,727 | 50,953 | 50,634 | 51,089 |
Diluted (in shares) | 51,396 | 51,558 | 51,368 | 51,620 |
Comprehensive income | $ 21,721 | $ 25,659 | $ 63,626 | $ 38,773 |
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Sep. 30, 2023 | Apr. 01, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 351,005 | $ 284,466 |
Accounts receivable, less allowance for credit losses of $5,044 at September 30, 2023 and $4,932 at April 1, 2023 | 174,249 | 179,142 |
Inventories, net | 285,830 | 259,379 |
Prepaid expenses and other current assets | 54,660 | 46,735 |
Total current assets | 865,744 | 769,722 |
Property, plant and equipment, net | 307,766 | 310,885 |
Intangible assets, less accumulated amortization of $433,092 at September 30, 2023 and $417,422 at April 1, 2023 | 250,504 | 275,771 |
Goodwill | 465,405 | 466,231 |
Deferred tax asset | 4,745 | 5,241 |
Other long-term assets | 117,111 | 106,975 |
Total assets | 2,011,275 | 1,934,825 |
Current liabilities: | ||
Notes payable and current maturities of long-term debt | 13,566 | 11,784 |
Accounts payable | 80,160 | 63,929 |
Accrued payroll and related costs | 45,638 | 64,475 |
Other current liabilities | 124,851 | 111,628 |
Total current liabilities | 264,215 | 251,816 |
Long-term debt, net of current maturities | 748,662 | 754,102 |
Deferred tax liability | 34,807 | 36,195 |
Other long-term liabilities | 69,931 | 74,715 |
Stockholders’ equity: | ||
Common stock, $0.01 par value; Authorized — 150,000,000 shares; Issued and outstanding — 50,740,389 shares at September 30, 2023 and 50,448,519 shares at April 1, 2023 | 507 | 504 |
Additional paid-in capital | 616,960 | 594,706 |
Retained earnings | 308,898 | 253,168 |
Accumulated other comprehensive loss | (32,705) | (30,381) |
Stockholders’ equity: | 893,660 | 817,997 |
Total liabilities and stockholders’ equity | $ 2,011,275 | $ 1,934,825 |
CEO | Mr. Christopher A. Simon |
---|---|
WEBSITE | www.haemonetics.com |
EMPLOYEES | 3034 |